Χώρα: Ηνωμένες Πολιτείες
Γλώσσα: Αγγλικά
Πηγή: NLM (National Library of Medicine)
TESTOSTERONE (UNII: 3XMK78S47O) (TESTOSTERONE - UNII:3XMK78S47O)
Bryant Ranch Prepack
TRANSDERMAL
PRESCRIPTION DRUG
Testosterone Gel 1% is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone: - Primary hypogonadism (congenital or acquired): testicular failure due to conditions such as cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome, orchiectomy, Klinefelter's syndrome, chemotherapy, or toxic damage from alcohol or heavy metals. These men usually have low serum testosterone concentrations and gonadotropins (follicle-stimulating hormone [FSH], luteinizing hormone [LH]) above the normal range. - Hypogonadotropic hypogonadism (congenital or acquired): gonadotropin or luteinizing hormone-releasing hormone (LHRH) deficiency or pituitary-hypothalamic injury from tumors, trauma, or radiation. These men have low testosterone serum concentrations, but have gonadotropins in the normal or low range. Limitations of use: - Safety and efficacy of Testosterone Gel 1% in men with “age-related hypogonadism” (also referred to as “late-onset
Testosterone Gel 1% is supplied in unit-dose aluminum foil packets in cartons of 30. Each packet of 2.5 g gel contains 25 mg testosterone. Storage Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Disposal Used Testosterone Gel 1% pumps or used Testosterone Gel 1% packets should be discarded in household trash in a manner that prevents accidental application or ingestion by children or pets.
Abbreviated New Drug Application
TESTOSTERONE- TESTOSTERONE GEL Bryant Ranch Prepack ---------- MEDICATION GUIDE TESTOSTERONE GEL 1% CIII (tes-TOS-te-ron) for topical use What is the most important information I should know about Testosterone Gel 1%? 1. Testosterone Gel 1 % can transfer from your body to others including, children and women. Children and women should avoid contact with the unwashed or not covered (unclothed) areas where Testosterone Gel 1% has been applied to your skin. Early signs and symptoms of puberty have occurred in young children who have come in direct contact with testosterone by touching areas where men have used Testosterone Gel 1%. Children Signs and symptoms of early puberty in a child when they come in direct contact with Testosterone Gel 1% may include: Abnormal sexual changes: • enlarged penis or clitoris. • early growth of hair near the vagina or around the penis (pubic hair). • erections or acting out sexual urges (sex drive). Behavior problems: • acting aggressively, behaving in an angry or violent way. Women Signs and symptoms in women when they come in direct contact with Testosterone Gel 1% may include: • changes in body hair • an abnormal increase in pimples (acne). Stop using Testosterone Gel 1% and call your healthcare provider right away ifyou see any signs and symptoms in a child or a woman that may have happened through accidental touching of the area where you have applied Testosterone Gel 1%. To lower the risk of transfer of Testosterone Gel 1% from your body to others, follow these important instructions: • Apply Testosterone Gel 1% only to areas of your shoulders, and upper arms, or stomach area (abdomen) that will be covered by a short sleeve t-shirt. • Wash your hands right away with soap and water after applying Testosterone Gel 1%. • After the gel has dried, cover the application area with clothing. Keep the area covered until you have washed the gel off the application area well or have showered. • If you expect to have skin-to-skin contact with another person, first wash Διαβάστε το πλήρες έγγραφο
TESTOSTERONE- TESTOSTERONE GEL BRYANT RANCH PREPACK ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE TESTOSTERONE GEL 1% SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR TESTOSTERONE GEL 1%. TESTOSTERONE GEL 1%, FOR TOPICAL USE CIII INITIAL U.S. APPROVAL: 1953 WARNING: SECONDARY EXPOSURE TO TESTOSTERONE SEE FULL PRESCRIBING INFORMATION FOR COMPLETE BOXED WARNING Virilization has been reported in children who were secondarily exposed to testosterone gel. (5.2, 6.2). Children should avoid contact with unwashed or unclothed application sites in men using testosterone gel. (2.2, 5.2) Healthcare providers should advise patients to strictly adhere to recommended instructions for use. (2.2, 5.2, 17). RECENT MAJOR CHANGES Warnings and Precautions (5.6) 10/2016 INDICATIONS AND USAGE Testosterone Gel 1% is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone: Primary hypogonadism (congenital or acquired). (1) Hypogonadotropic hypogonadism (congenital or acquired). (1) Limitations of use: Safety and efficacy of Testosterone Gel 1% in men with “age-related hypogonadism” have not been established. (1) Safety and efficacy of Testosterone Gel 1% in males less than 18 years old have not been established. (8.4) Topical testosterone products may have different doses, strengths or application instructions that may result in different systemic exposure. (1, 12.3) DOSAGE AND ADMINISTRATION DOSAGE AND ADMINISTRATION FOR TESTOSTERONE GEL 1% DIFFERS FROM TESTOSTERONE GEL 1.62 %. FOR DOSAGE AND ADMINISTRATION OF TESTOSTERONE GEL 1.62% REFER TO ITS FULL PRESCRIBING INFORMATION. (2) Prior to initiating Testosterone Gel 1%, confirm the diagnosis of hypogonadism by ensuring that serum testosterone has been measured in the morning on at least two separate days and that these concentrations are below the normal range. (2) Starting dose of Testosterone Gel 1% is 50 mg of testosterone (4 pump a Διαβάστε το πλήρες έγγραφο